• Home
  • Top Stories
  • Markets
  • Market Data
  • Companies
  • Opinion
  • Economy & Policy
  • Finance
  • Politics
  • Technology
  • Personal Finance
  • Current Affairs
  • International
  • Management
  • Weekend
  • General News
  • Latest News
  • Today's Paper
  • Videos
  • Covid-19
  • Portfolio
  • Login

Zydus Cadila
Zydus Cadila gets USFDA nod for cancer, high blood pressure treatment drug
Zydus seeks DCGI nod for add'l indication of Hep C drug in Covid-19 therapy
Zydus Cadila seeks approval for its repurpose Hepatitis C drug for Covid-19
Zydus Cadila receives tentative nod from USFDA to market two HIV drugs
Zydus Cadila reduces price of generic Covid-19 drug to Rs 899 per vial

Zydus Cadila gets USFDA final nod for low blood pressure drug Droxidopa
More Covid-19 vaccine candidates get approval for clinical trials in India
More Covid-19 vaccine candidates get approval for clinical trials in India
Zydus Cadila's Q3 net up 41% to Rs 527 cr on strong India biz growth
Zydus Cadila says 'positive results' from phase 2 studies of Covid-19 drug

Next 
⇧ Back to Top
  • Top Stories
  • Markets
  • Market Data
  • Companies
  • Opinion
  • Economy & Policy
  • Finance
  • Politics
  • Technology
  • Personal Finance
  • Current Affairs
  • International
  • Budget 2021
  • Insurance Round Table 2020
View Full Site >>
Copyrights © 2021 Business Standard Private Ltd. All rights reserved